Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly: Steep Pullback, Still Compelling Here
LLY's recent sell-off presents a buying opportunity for savvy investors, with strong growth potential in the GLP-1 market ahead. Explore more here.
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
From there, the case for or against investing in Lilly should become much clearer. Eli Lilly's earnings report
Massive Insider Trade At Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly Stock: Unexpected Developments (Rating Downgrade)
Eli Lilly faces challenges with slowing drug sales and a lawsuit against the HRSA. Learn why caution is advised for LLY stock despite its lower P/E ratio.
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
Conditions are getting a bit more challenging for the drugmaker.
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Eli Lilly, Novo Nordisk, and Amgen all look cheap. All of them could experience a massive boost to profits in the years to come.
4h
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
After flying high during the first half of the year, pharmaceutical giant Eli Lilly (NYSE: LLY) has lost some momentum; the ...
6d
on MSN
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
The Motley Fool on MSN
3d
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Eli
Lilly
now ranks as the largest drugmaker in the world based ... Much of
Lilly
's recent dismal stock performance ...
Yahoo Finance
2d
Eli Lilly and Company (LLY)
In this piece, we will look at where
Eli
Lilly
and Company
(NYSE:LLY) ranks on the list. With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future ...
3d
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial
The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
3d
Eli Lilly and Company: Lilly announces changes on board of directors
Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors ...
2d
Eli Lilly and China-based biotech Laekna team on obesity drug
Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its ...
4d
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Jim Cramer
Laekna
Feedback